About Taimour Langaee
Dr. Langaee is a Research Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.
Dr. Langaee’s research interests are focused on pharmacogenomics (genetic-based variability in drug response) and Precision Medicine, Infectious Disease and Microbial Resistance to Beta-lactam Antibiotics, developing microarray-based technology methods to facilitate disease diagnosis, developing genotype-phenotype translation table, genotyping, and discovering disease-gene associations.
Dr. Langaee’s research interests are focused on Pharmacogenomics and Personalized Medicine, Development and application of Clinical Diagnostic Genetic Biomarkers, Pharmacogenetics of Dichloroacetate (DCA), Infectious Disease and Microbial Resistance to Beta-lactam antibiotics.